TRACON Pharmaceuticals Inc (TCON)
1.79
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
1.79
0.00 (0.00%)
After-Hours: 19:59
TRACON Pharmaceuticals Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -1.371 |
| September 30, 2022 | -3.452 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.2502 |
| December 31, 2021 | 0.1187 |
| September 30, 2021 | 0.1102 |
| June 30, 2021 | 0.2317 |
| March 31, 2021 | 0.1688 |
| December 31, 2020 | 0.1639 |
| September 30, 2020 | 0.2934 |
| June 30, 2020 | 1.501 |
| March 31, 2020 | 1.69 |
| December 31, 2019 | 1.980 |
| September 30, 2019 | 1.48 |
| June 30, 2019 | 0.7392 |
| Date | Value |
|---|---|
| March 31, 2019 | 0.4397 |
| December 31, 2018 | 0.2997 |
| September 30, 2018 | 0.2221 |
| June 30, 2018 | 0.1693 |
| March 31, 2018 | 0.1588 |
| December 31, 2017 | 0.438 |
| September 30, 2017 | 0.3357 |
| June 30, 2017 | 0.4166 |
| March 31, 2017 | 0.3084 |
| December 31, 2016 | 0.2634 |
| September 30, 2016 | 0.4679 |
| June 30, 2016 | 0.5066 |
| March 31, 2016 | 0.3556 |
| December 31, 2015 | 0.2854 |
| September 30, 2015 | 0.1686 |
| June 30, 2015 | 0.1456 |
| March 31, 2015 | 0.1585 |
| December 31, 2014 | -0.2777 |
| September 30, 2014 | -0.3192 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-3.452
Minimum
Sep 2022
1.980
Maximum
Dec 2019
0.2055
Average
0.1639
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| BioSig Technologies Inc | 0.00 |
| Revolution Medicines Inc | 0.00 |
| Perspective Therapeutics Inc | 0.0229 |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.4243 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.10M |
| Total Liabilities (Quarterly) | 10.91M |
| Shareholders Equity (Quarterly) | -0.809M |
| Current Ratio | 0.8928 |
| Net Debt Paydown Yield | 23.47% |